Status:
RECRUITING
A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Analgesia
Pain, Acute
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study will compare three different doses of perineural dexmedetomidine 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg as adjuvants to local anesthetics for ultrasound-guided infraclavicular brachial plex...
Detailed Description
With the approval of Ethics Committee of the McGill University Health Centre, a total of 69 patients undergoing upper extremity surgery (elbow and below) will be recruited. Recruitment will be carried...
Eligibility Criteria
Inclusion Criteria:
- patients undergoing upper limb surgery at or below the elbow
- age between 18 and 75 years
- American Society of Anesthesiologists classification 1-3
- body mass index between 18 and 35 kg/m2
Exclusion Criteria:
- adults who are unable to give their own consent
- allergy or contraindication to dexmedetomidine
- exposure to dexmedetomidine during the previous 48 hrs
- pre-existing neuropathy (assessed by history and physical examination)
- coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood workup i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or partial prothrombin time ≥ 50)
- renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. creatinine. eGFR < 90)
- hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. transaminases ≥ 100)
- allergy to LA
- pregnancy (as institutional policy, female patients with childbearing potential undergoing non urgent surgery are tested preoperatively for pregnancy with blood tests)
- breast feeding
- prior surgery in the infraclavicular region
- chronic pain syndromes requiring opioid intake at home
Key Trial Info
Start Date :
December 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT07249827
Start Date
December 28 2025
End Date
June 30 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Centre
Montreal, Quebec, Canada, H3G 1A4